Navigation Links
Global Call for Mercury-free Vaccines Issued
Date:3/15/2012

SILVER SPRING, Md., March 15, 2012 /PRNewswire-USNewswire/ -- In a historic open letter to the World Health Organization and other public health agencies, the Coalition for Mercury-Free Drugs (CoMeD), and the United Methodist Women are seeking to stop the use of mercury in human drugs, especially vaccines.  Currently, the mercury-based preservative Thimerosal, which is 49% mercury by weight, remains in vaccines for the United States and much of the world, despite the fact that it is a known neurotoxin.  While other safer and less toxic alternatives are being utilized, industry has been slow to eliminate Thimerosal from many vaccines, including the flu shot given to those most vulnerable to this toxin, children and pregnant women.

The goal of the United Methodist Women and CoMeD is to protect the global immunization program and to safeguard public confidence in vaccines by seeing that the addition of mercury to human pharmaceuticals ceases.  Through the ongoing diplomatic work of the Intergovernmental Negotiation Committee of the United Nations Environment Programme, these organizations hope to impact the formulation of a global, legally binding treaty on mercury scheduled to be completed in 2013.

In these negotiations, the World Health Organization and other global distributors of vaccines have defended the continuing use of mercury, especially in vaccines.  They maintain that there is no evidence of harm from Thimerosal.  Dr. Mark R. Geier, a CoMeD director, cautions, "Recent statements by those holding national and global responsibility for vaccine safety are difficult to reconcile with the known and published toxicity of Thimerosal."  Eight decades of scientific literature have shown that Thimerosal poses a significant health risk and its manufacturers acknowledge it can cause mild to severe mental retardation in children.

The United Methodist Church passed the first global resolution "Protecting Children from Mercury-containing Drugs," and the United Methodist Women have actively advocated for a ban of mercury in medicine on moral and ethical grounds.  As the Rev. Lisa K. Sykes, the author of the original draft of the United Methodist global resolution, asserts, "The United Methodist Women have historically advocated in the areas of education and health, both in this country and around the world. Undertaking the issue of mercury in vaccines and other drugs is just one expression of that commitment." 

The United Methodist Women and CoMeD support every effort to make safer vaccines, those without added mercury, equally available to all persons around the globe.


'/>"/>
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory ... hygiene symposium in Mystic, CT. Covering the process and maintenance strategies of gum ... these popular periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists ...
(Date:6/27/2017)... , ... June 27, 2017 , ... ... . Orthodontics is a dental specialty that focuses on treating alignment and occlusion ... improved aesthetics and function. , North Hollywood dentist , Dr. Garemani, ...
(Date:6/26/2017)... ... ... Center is now offering various types of dental implants to restore lost teeth. Dental implants ... such as crowns, bridges, or dentures. An implant is placed directly into the jawbone where ... tooth. , Several types of dental implants are available, including: , ...
(Date:6/26/2017)... Ruidoso, New Mexico (PRWEB) , ... June 26, ... ... sexual dysfunction, anorgasmia, and urinary leakage is revolutionizing the way women look and ... Mexico is tackling the problem of female sexual dysfunction and urinary leakage head ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... New patients ... from Dr. Angela Cotey, with or without a referral. Dr. Cotey is a trusted ... of this preferred tooth replacement option. , Patients with missing teeth in Fitchburg, WI, ...
Breaking Medicine News(10 mins):